Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS
No-Receipt date
2021-01557 - 22/04/2021
No-Filing date
20210401073 - 22/04/2021
No-Granting date
3107004 - 28/04/2021
No-EPO application date
16750766.4 - 05/08/2016
No-EPO granting date
3331900 - 17/02/2021
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
4/2021 - 19/05/2021
Expiration date
06/08/2036
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US201562201289 P05/08/2015/US
GB20151392106/08/2015/GB
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
G01N 33/574
C12N 15/115
C07K 14/725
C07K 14/47
A61P 35/00
A61K 39/00
A61K 38/00
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1291185
IMMATICS BIOTECHNOLOGIES GMBH
PAUL-EHRLICH-STRASSE 15
72076 TUBINGEN
GERMANY
Inventors
Code
Firstname
Surname
3303427
MAHR, ANDREA
3303428
WEINSCHENK, TONI
3303429
SCHOOR, OLIVER
3303430
FRITSCHE, JENS
3303431
SINGH, HARPREET
3303432
MULLER, PHILLIP
3303433
LEIBOLD, JULIA
3303434
GOLDFINGER, VALENTINA
Representatives
Code
Firstname
Surname
Address
Town
Zip
3089
NIKOLAOS
LYMPERIS "DIKIGORIKI ETAIREIA VAGIANOU KOSTOPOULOU LYMPERI"
STOURNARI 37
ATHINA (ATTIKIS)
10682
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
7915
NIKOLAOS
LYMPERIS
STOURNARI 37
ATHINA (ATTIKIS)
10682
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
3/6/2025 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 02/2025 Αρ. Πρωτ. ΓΔ 775 / 06.03.2025
Payments history
8 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).